IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹969 Cr | ₹1,014 Cr | ₹902 Cr | ₹614 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹969 Cr |
| Mar2024 | ₹1,014 Cr |
| Mar2023 | ₹902 Cr |
| Mar2022 | ₹614 Cr |
| Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹969 Cr | -4.46 | |
| Mar2024 | ₹1,014 Cr | 12.50 | |
| Mar2023 | ₹902 Cr | 46.89 | |
| Mar2022 | ₹614 Cr | 223.62 | |
| Mar2021 | ₹190 Cr | - | |
Compare Total Non-Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹35,866.8 Cr | 0.3% | 0.6% | -9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 0.3% |
0.6% |
-9.5% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses